The skyrocketing demand for GLP-1 weight-loss medications has led to a surge in compounding pharmacies producing similar products at lower prices, but researchers warn that these medications are not always as safe as they claim
Wilding JPH, Kwan AYM, Maldonado JM, Wang H, Rasouli N (2022) Tirzepatide induces weight loss in patients with type 2 diabetes regardless of baseline BMI: a post hoc analysis of SURPASS-1 through SURPASS-5 studies
You will need a diagnosis of type 2 diabetes, hypertension, high cholesterol, cardiovascular disease, or sleep apnea to qualify
When central sensitization occurs, these fibers begin triggering pain circuits they were never designed to activate
Unlike supplements or diet pills, these treatments are FDA-approved and designed to work as part of a supervised medical weight loss program
The defense will be able to present opposing evidence in a non-adversarial format